Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Folic Acid Supplementation to Reduce the Severity of Anemia and Blood Transfusions in Extremely Preterm Infants

NCT06220461 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT06220461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06220461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Folic Acid Supplementation to Reduce the Severity of Anemia and Blood Transfusions in Extremely Preterm Infants
Lead sponsor
University of Calgary
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 1, 2024
Completion date
July 31, 2028
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia of prematurity, extreme prematurity